12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Other News

Watson, Covidien neurology news

Watson and Covidien's Mallinckrodt Inc. subsidiary settled a December 2010 suit filed in the U.S. District Court for the District of New Jersey claiming that Watson infringed U.S. Patent No. 5,914,131 covering pain drug Exalgo hydromorphone....

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >